Navigation Links
Scotland Announces New Life Science Leadership and Investments at BIO 2010
Date:4/29/2010

CHICAGO, April 29 /PRNewswire/ --  Scotland will showcase the talent and collaborative spirit that has attracted many of the world's leading pharma and biotech companies to its shores at this year's BIO conference, May 3-6 in Chicago.  Heading into the conference, Scottish Enterprise and sector leaders believe Scottish research and the nation's unique integrated industry approach will continue to fuel life sciences growth, particularly in scientific infrastructure, stem cell therapeutics and translational medicine.

"BIO offers Scotland an extraordinary opportunity to demonstrate our cluster's wealth of scientific talent and our ability to innovate R&D across business, academic and government sectors, ultimately providing an energised, strategic location for life science investment and commercialisation," said Rhona Allison, Senior Director Life Sciences, Scottish Enterprise. "The ability of our sector leaders to collaborate and solve the many challenges facing today's life sciences industry is essential to helping companies safely and effectively deliver new therapies and products to patients."

At BIO, Scotland will feature:

  • Scotland's investment in translational medicine, with Ross McLennan of the Scottish Academic Health Sciences Collaboration (SAHSC) offering insights into how the program, launched last year by the Chief Scientist's Office, enhances Scotland's unique ability to streamline patient-oriented clinical research for pharmaceutical companies through collaboration between NHS Scotland and the nation's universities.
  • New Scottish Stem Cell Network CEO Kevin Price discussing Scotland's position as one of Europe's largest and most highly-regarded stem cell research communities and its role as home to groundbreaking regenerative medicine research such as ReNeuron's stem cell trial for stroke patients.
  • Leadership in creating a best-in-class environment for global innovation exemplified with representation of twenty-two leading Scottish life sciences organisations with support from SE/SDI.
  • Scotland as a location of choice for world-class businesses to collaborate and succeed. The Edinburgh BioQuarter, a major collaboration between Scottish Enterprise, Alexandria Real Estate Equities, Inc., University of Edinburgh and the National Health Service is an offering which exemplifies the excellence of research, clinical and commercial opportunities open to a company  locating in Scotland.  Newly appointed CEO Dr. Michael Capaldi and Chair Dr. Simon Best will discuss investments to make the BioQuarter one of the world's leading hubs for commercialization of life sciences research.

"Scotland is an exciting place to be for life sciences companies and innovators at the moment," said Allison.  "The energy, expertise and unprecedented momentum around our research and commercialisation activities are making Scotland and its collaborative approach an attractive home for cutting-edge investment."

Scotland will also present two interactive panel sessions on Monday, May 3. "From Oligos to Genes to Pathways to Genomes: DNA construction for Synthetic Biology" will cover the emerging field of synthetic biology and Scottish Enterprise's 2.4 million pounds sterling ($3.6 million) Genome Segment Assembly (GSA) research program. "Lost in Translation: Translational R&D as the Road Map to Market" will share global best practices in translational R&D.

Scottish Organizations at BIO

Aquapharm Biodiscovery Limited

Biotech Innovation & Future Health Limited

Borders Technology Management

ChimaeraBio

CXR Biosciences Ltd

GlycoMar Limited

GT Biologics Limited

Ingenza Ltd

Marks & Clerk LLP

Murgitroyd & Company

NovaBiotics Ltd

Ocutec Limited

Sistemic

Solid Form Solutions Ltd

Talent Scotland

University of Aberdeen – Research & Innovation

University of Dundee – Research & Innovation Services

University of Edinburgh – College of Medicine & Veterinary Medicine

University of Edinburgh – Edinburgh Research and Innovation

University of Edinburgh – MRC Centre for Regenerative Medicine

For more information on these companies, please visit Scottish Development International.

For further information on Scotland at BIO, please contact Emily Hyman at 617-520-7094 or ehyman@webershandwick.com.  


'/>"/>
SOURCE Scottish Enterprise; Scottish Development International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
2. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
3. Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT ... (the "Company" or "Propellon"), a start-up created by ... anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive capital, ... program. The seed funding enables Propellon to accelerate ... the Company for financing and/or entering a strategic ...
Breaking Biology Technology:
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
(Date:2/26/2017)... DALLAS , Feb. 25, 2017  Securus ... justice technology solutions for public safety, investigation, corrections ... of Recidivism and Reentry. "Too often, ... State prisons and county jails are trying to ... of inmates and friends and family members. While significant ...
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
Breaking Biology News(10 mins):